FRANKLIN COVEY CO FC
Franklin Covey is a global company focused on organizational performance improvement. Our mission is to "enable greatness in people and organizations everywhere," and our global structure is designed to help individuals and organizations achieve results that require collective behavior change. From the foundational work of Dr. Stephen R. Covey in leadership and personal effectiveness, and Hyrum W. Smith in productivity and time management, we have developed deep expertise that extends to helping organizations and individuals achieve desired results through lasting behavioral change. We believe that our clients are able to utilize our content and offerings to create cultures which include high-performing, collaborative individuals, led by effective, trust-building leaders who execute with excellence and deliver measurably improved results for all of their key stakeholders.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- Americas
- Asia Pacific
- Europe/Middle East/Africa
| Region | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Americas | $226.8M | $242.5M | $233.5M |
| Asia Pacific | $23.1M | $26.8M | $28.6M |
| Europe/Middle East/Africa | $17.2M | $17.9M | $18.4M |
As the company reported it, from the “Segment Information (Schedule Of Disaggregated Revenue By Geographic Region) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $267.1M | $287.2M | $280.5M | $262.8M | $224.2M | $198.5M | $225.4M | $209.8M | $185.3M | $200.1M |
| Cost of revenue | $63.5M | $66.2M | $67.0M | $60.9M | $51.3M | $53.1M | $66.0M | $61.5M | $62.6M | $64.9M |
| Gross profit | $203.6M | $221.1M | $213.5M | $201.9M | $172.9M | $145.4M | $159.3M | $148.3M | $122.7M | $135.2M |
| SG&A | $182.7M | $175.9M | $178.0M | $168.1M | $153.6M | $130.0M | $140.5M | $138.3M | $121.1M | $113.6M |
| Operating income | $5.7M | $33.0M | $26.4M | $23.7M | $8.1M | $3.1M | $2.7M | -$3.4M | -$8.9M | $13.8M |
| Interest expense | $565.0K | $1.1M | $1.6M | $1.7M | $2.1M | $2.3M | $2.4M | $2.7M | $2.4M | $2.3M |
| Pre-tax income | $6.1M | $33.0M | $25.9M | $22.1M | $6.1M | $796.0K | $592.0K | -$5.5M | -$10.9M | $11.9M |
| Income tax | $3.0M | $9.6M | $8.1M | $3.6M | $7.5M | $10.2M | $1.6M | $367.0K | $3.7M | $4.9M |
| Net income | $3.1M | $23.4M | $17.8M | $18.4M | $13.6M | -$9.4M | -$1.0M | -$5.9M | -$7.2M | $7.0M |
| EPS, basic | 0.24 | 1.78 | 1.30 | 1.30 | 0.97 | -0.68 | -0.07 | — | -0.52 | 0.47 |
| EPS, diluted | 0.24 | 1.74 | 1.24 | 1.27 | 0.96 | -0.68 | -0.07 | -0.43 | -0.52 | 0.47 |
| Shares, diluted (wtd. avg.) | 13.1M | 13.5M | 14.3M | 14.6M | 14.1M | 13.9M | 13.9M | 13.8M | 13.8M | 15.1M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $31.7M | $48.7M | $38.2M | $60.5M | $47.4M | $27.1M | $27.7M | $10.2M | $8.9M | $10.5M |
| Receivables | $68.4M | $86.0M | $81.9M | $72.6M | $70.7M | $56.4M | $73.2M | $71.9M | $66.3M | $66.0M |
| Inventory | $5.2M | $4.0M | $4.2M | $3.5M | $2.5M | $3.0M | $3.5M | $3.2M | $3.4M | $5.0M |
| Total current assets | $129.5M | $160.3M | $145.0M | $155.9M | $136.7M | $101.7M | $119.3M | $100.2M | $91.8M | $89.7M |
| Property, plant and equipment | $14.3M | $8.7M | $10.0M | $9.8M | $11.5M | $15.7M | $18.6M | $21.4M | $19.7M | $16.1M |
| Goodwill | $31.2M | $31.2M | $31.2M | $31.2M | $31.2M | $24.2M | $24.2M | $24.2M | $24.2M | $19.9M |
| Other intangibles | $34.6M | $37.8M | $40.5M | $44.8M | $50.1M | $47.1M | $47.7M | $51.9M | $57.3M | $50.2M |
| Total assets | $242.9M | $261.5M | $245.9M | $259.2M | $249.7M | $205.4M | $224.9M | $213.9M | $210.7M | $190.9M |
| Accounts payable | $8.8M | $7.9M | $6.5M | $10.9M | $6.9M | $5.6M | $9.7M | $9.8M | $9.1M | $10.4M |
| Short-term debt | — | — | — | — | — | — | — | $2.1M | $1.9M | $1.7M |
| Total current liabilities | $157.3M | $162.5M | $151.6M | $153.8M | $136.5M | $102.5M | $103.5M | $94.8M | $80.6M | $54.1M |
| Long-term debt | — | — | — | — | $18.8M | — | — | — | — | — |
| Total liabilities | $176.0M | $178.4M | $167.3M | $176.3M | $169.8M | $146.0M | $142.9M | $133.4M | $125.7M | $97.2M |
| Retained earnings | $126.3M | $123.2M | $99.8M | $82.0M | $63.6M | $50.0M | $59.4M | $63.6M | $69.5M | $76.6M |
| Total equity | $66.9M | $83.1M | $78.7M | $82.8M | $79.9M | $59.5M | $82.0M | $80.5M | $85.1M | $93.7M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $29.0M | $60.3M | $35.7M | $52.3M | $46.2M | $27.6M | $30.5M | $16.9M | $17.4M | $32.7M |
| Depreciation and amortisation | $4.1M | $3.9M | $4.3M | $4.9M | $6.2M | $6.7M | $6.4M | $10.5M | $7.4M | $6.9M |
| Stock-based compensation | $5.8M | $10.1M | $12.5M | $8.3M | $8.6M | -$573.0K | $4.8M | $2.8M | $3.7M | $3.1M |
| Capital expenditure | $8.3M | $3.7M | $4.5M | $3.2M | $1.6M | $4.2M | $4.2M | $6.5M | $7.2M | $4.0M |
| Investing cash flow | -$16.9M | -$11.3M | -$13.6M | -$5.3M | -$14.3M | -$11.9M | -$6.9M | -$10.6M | -$21.7M | -$6.2M |
| Financing cash flow | -$28.8M | -$38.7M | -$44.2M | -$32.7M | -$11.5M | -$16.6M | -$5.9M | -$4.7M | $3.1M | -$32.5M |
| Buybacks | $26.4M | $30.7M | $35.6M | $23.9M | $3.0M | $14.0M | $12.0K | $2.0M | $5.4M | $43.6M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000886206-25-000085.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $200.1M | $185.3M | $209.8M | $225.4M | $198.5M | $224.2M | $262.8M | $280.5M | $287.2M | $267.1M |
| Gross profit | $135.2M | $122.7M | $148.3M | $159.3M | $145.4M | $172.9M | $201.9M | $213.5M | $221.1M | $203.6M |
| Net income | $7.0M | -$7.2M | -$5.9M | -$1.0M | -$9.4M | $13.6M | $18.4M | $17.8M | $23.4M | $3.1M |
Recent filings and events
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Results announced Item 2.02
- Regulation FD disclosure Item 7.01
- Other event Item 8.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Results announced Item 2.02
- Regulation FD disclosure Item 7.01
- Other event Item 8.01
- Officer or director change Item 5.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 8741
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| IT | GARTNER INC | $14.54B | 23.9x | 3.7% |
| EVH | Evolent Health, Inc. | $542.7M | — | -26.6% |
| RTO | RENTOKIL INITIAL PLC /FI | — | — | — |
| TDIC | Dreamland Ltd | — | — | — |